OTT: Annual Celebration: 2022 Significant Event of the Year @emoryuniversity
OTT: Annual Celebration: 2022 Significant Event of the Year  @emoryuniversity
Uploaded May 2022 | Updated November 2026, 2 days ago
SIGNIFICANT EVENT OF THE YEAR
FDA EMERGENCY USE AUTHORIZATION OF MOLNUPIRAVIR
GREGORY BLUEMLING, PHD; GEORGE PAINTER III, PHD; MICHAEL NATCHUS, PHD; DAVID GUTHRIE, PHD; DAVID PERRYMAN, JD
Throughout the COVID-19 pandemic, there has been an incredibly large strain across the globe. Molnupiravir, an antiviral therapeutic against certain RNA viruses, was invented at Emory through the Drug Innovation Ventures at Emory (DRIVE). The therapeutic was sub-licensed to Ridgeback Biotherapeutics in 2020. It was found that molnupiravir could treat mild-to-moderate COVID-19 infections in those that are at a high risk for hospitalization or death, with the ultimate goal of keeping COVID-19 patients out of the hospital. On December 23, 2021, the U.S. Food and Drug Administration granted Emergency Use Authorization of molnupiravir for the treatment of COVID-19.

More information: https://www.ott.emory.edu/about/annual-celebrations/index.html
OTT: Annual Celebration: 2022 Significant Event of the YearOxford Launch: LondonThe Gilded Age and Historical Accuracy -Executive Producer and #emory professor Dr. Dunbar2026 Raymond Danowski Poetry Library Reading featuring Danez SmithEmory Libraries Preservation DepartmentEmory University Welcomes You to AtlantaEmory Move In 2023From Social Death, Laboratory Life: Race, Diabetes, and the Science of InclusionOxford Olympics 2023Emory Neuroscience Phd Student & Decathlon World Champion Nikki BoonHow multicellular life may have evolvedEmory Faculty Spotlight: Emmy nominated Erica Dunbar on The Gilded Age
Emory University |

OTT: Annual Celebration: 2022 Significant Event of the Year

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER